Skip to main content

Market Overview

Nomura Trading Up After Inaccurate Story; Stock Was Upgraded 2 Weeks Ago

Share:
Nomura Trading Up After Inaccurate Story; Stock Was Upgraded 2 Weeks Ago

Shares of Nomura Holdings, Inc. (NYSE: NMR) surged more than 5 percent on Monday and established a new 52-week high of $7.23.

At a time when financial-related stocks are trading lower as a result of Greece's referendum result, the move higher in Nomura's stock warranted a second look.

One possible explanation for the move higher was a report by Insider Trading Report which stated that shares of the Japan-based global investment and financial services business received an upgrade to Equal-weight from Underperform by analysts at Barclays.

The report appears incorrect. Shares of Nomura were actually upgraded on June 23 by Barclay's Japan-based analyst Azuma Ohno.

The Insider Trading Report story has since been removed.

Related Link: Deutsche Bank Stock Is Dropping More Than Other Peers After Greek News

"Core business earnings have been stable, mainly led by the retail business, and we expect expansion of investment-trust fees and wrap-account income to strengthen consolidated profit absent a sudden change in the market environment," Ohno wrote. "The wrap-account balance is growing at a faster pace than at Daiwa [Japan's second largest securities brokerage after Nomura], and we anticipate a large contribution by wrap-related income to profit growth in the retail business."

Ohno also noted that within Nomura's wholesale division, overseas income has improved to breakeven level and is expected to deliver a profit from overseas business in the third quarter 2016, including "anticipated income from a major IPO."

Ohno also stated that Nomura's investors could expect dividend increases that correspond to the company's growing profit trend. In addition, the company could institute a buyback program if profit "overshoots."

Latest Ratings for NMR

DateFirmActionFromTo
Mar 2021Goldman SachsDowngradesBuyNeutral
Mar 2021Goldman SachsUpgradesNeutralBuy
Sep 2016JefferiesUpgradesUnderperformHold

View More Analyst Ratings for NMR

View the Latest Analyst Ratings

 

Related Articles (NMR)

View Comments and Join the Discussion!

Posted-In: Azuma Ohno Barclays Daiwa Insider Trading ReportAnalyst Color Top Stories Intraday Update Analyst Ratings Best of Benzinga

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com